STAT1-STAT3 activation between pDC and CD24+CD38high Breg cell interaction was restored in SLE patients responding to rituximab, a chimeric monoclonal antibody targeted against the CD20 marker (50). This evidence concerns the gene STAT1 and systemic lupus erythematosus.